{"title":"Adult Left Liver Transplantation With Mesocaval Shunt With Porto-Mesenteric Disconnection: Long-Term Outcome","authors":"Jérôme Dumortier, Sophie Chopinet, Romain L'Huillier, Serban Puia-Negulescu, Mustapha Adham, Laurent Milot, Olivier Boillot","doi":"10.1111/ctr.70292","DOIUrl":null,"url":null,"abstract":"<p>Aiming to decrease portal venous pressure and to minimize the risk of small-for-size syndrome when using a partial liver graft for liver transplantation (LT), surgical techniques modulating venous portal inflow have been proposed. We report here our experience on the long-term outcome after adult left split LT with mesocaval shunt (MCS) with porto-mesenteric disconnection (PMD). Between March 1996 and March 2010, 33 adult patients underwent LT from a full-right/full-left SLT for two adult recipients; portal vein inflow modulation through a MCS with PMD was realized in 10 cases. The study population consisted of 13 left liver and 15 right liver recipients who survived more than 1 year without retransplantation. The technique of mesenterico-portal disconnection with MCS which allowed to decrease the mean portal vein pressure to 14.2 mm Hg, was applied in six recipients who survived more than 1 year without retransplantation: five males and one female, with a mean age of 60 years (range: 53–66) who all received a left split graft, with a mean weight and GRWR of 562 g (range: 430–740) and 0.79% (range: 0.61–0.98), respectively. During follow-up, four patients with MCS (4/6) experienced hyperammonemic encephalopathy, after a mean delay of 9.1 ± 7.9 years after LT (ranging 2.6–20.1). The outcome was favorable with symptomatic treatment with lactulose ± rifaximin in all cases except one, who underwent surgical closure of the shunt. In conclusion, our results emphasize that portal vein inflow modulation through MCS during LT can be complicated by late occurrence of hyperammonemic encephalopathy.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 9","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70292","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70292","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Aiming to decrease portal venous pressure and to minimize the risk of small-for-size syndrome when using a partial liver graft for liver transplantation (LT), surgical techniques modulating venous portal inflow have been proposed. We report here our experience on the long-term outcome after adult left split LT with mesocaval shunt (MCS) with porto-mesenteric disconnection (PMD). Between March 1996 and March 2010, 33 adult patients underwent LT from a full-right/full-left SLT for two adult recipients; portal vein inflow modulation through a MCS with PMD was realized in 10 cases. The study population consisted of 13 left liver and 15 right liver recipients who survived more than 1 year without retransplantation. The technique of mesenterico-portal disconnection with MCS which allowed to decrease the mean portal vein pressure to 14.2 mm Hg, was applied in six recipients who survived more than 1 year without retransplantation: five males and one female, with a mean age of 60 years (range: 53–66) who all received a left split graft, with a mean weight and GRWR of 562 g (range: 430–740) and 0.79% (range: 0.61–0.98), respectively. During follow-up, four patients with MCS (4/6) experienced hyperammonemic encephalopathy, after a mean delay of 9.1 ± 7.9 years after LT (ranging 2.6–20.1). The outcome was favorable with symptomatic treatment with lactulose ± rifaximin in all cases except one, who underwent surgical closure of the shunt. In conclusion, our results emphasize that portal vein inflow modulation through MCS during LT can be complicated by late occurrence of hyperammonemic encephalopathy.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.